Alvaro Hidalgo

Profesor Titular de Universidad

University of Castilla-La Mancha

Spain

Research Interests

Explore related searches

Professors in Spain

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (10)

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2021

Collaborators (3)

Antonio J Garcia Ruiz

Profesor Titular de Universidad – TU/ Catedrático de Escuela Universitaria - CEU

University of Malaga

SPAIN

View details

Ruth Vera

Chief of the department

Hospital Universitari Arnau de Vilanova

SPAIN

View details

jose-manuel carrascosa

head of department, associated professor

Hospital Universitari Germans Trias i Pujol

SPAIN

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Alvaro Hidalgo

Research Interests

Explore related searches

Contact this professor

Articles (10)

The social value of a PASI 90 or PASI 100 response in patients with moderate-to-severe plaque psoriasis in Spain.

Optimising the management of patients with multiple myeloma in Spain: A measurement of the social return on investment.

A Social Return on Investment Analysis of Improving the Management of Chronic Obstructive Pulmonary Disease Within the Spanish National Healthcare System.

Assessing the value contribution of bimekizumab for the treatment of moderate-to-severe psoriasis using a multidisciplinary reflective multi-criteria decision analysis.

The economic burden of pulmonary arterial hypertension in Spain.

Unmet Needs in the Management of Moderate-to-Severe Psoriasis in Spain: A Multidimensional Evaluation.

A multicriteria decision analysis (MCDA) applied to three long-term prophylactic treatments for hereditary angioedema in Spain.

A strategic reflection for the management and implementation of CAR-T therapy in Spain: an expert consensus paper.

The impact of improving haemophilia A management within the Spanish National Healthcare System: a social return on investment analysis.

Impact of Remdesivir on the Treatment of COVID-19 During the First Wave in Spain.

Collaborators (3)

Antonio J Garcia Ruiz

Ruth Vera

jose-manuel carrascosa

Make your next move.